Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Wednesday, November 05, 2014 9:59:11 AM
bullish
$RGLS recent news/filings
## source: finance.yahoo.com
Wed, 05 Nov 2014 12:07:09 GMT ~ Q3 2014 Regulus Therapeutics Inc Earnings Release - After Market Close
read full: http://biz.yahoo.com/research/earncal/20141105.html?t=rgls
*********************************************************
Mon, 03 Nov 2014 22:01:52 GMT ~ Regulus Announces Closing of Public Offering of $103.5M of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
[at noodls] - LA JOLLA, Calif., Nov. 3, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today ...
read full: http://www.noodls.com/view/FC7FB74389DE616F3511E9EC80B38E536089B6F9
*********************************************************
Mon, 03 Nov 2014 21:05:00 GMT ~ Regulus Announces Closing of Public Offering of $103.5M of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
[PR Newswire] - LA JOLLA, Calif., Nov. 3, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced the closing of its previously announced underwritten public offering of $103.5 million of shares of its common stock, including $13.5 million of shares sold pursuant to the full exercise of the underwriters' option to purchase additional shares, at a price to the public of $17.00 per share. Of the total 6,088,235 shares sold in the offering, 4,808,824 shares were sold by Regulus and 1,279,411 shares were sold by an existing stockholder of Regulus, Isis Pharmaceuticals, Inc. (ISIS). The net proceeds to Regulus from the offering are expected to be approximately $76.1 million after deducting underwriting discounts and commissions and other estimated offering expenses payable by Regulus. Regulus will not receive any proceeds from the sale of shares by Isis. Deutsche Bank Securities and BMO Capital Markets acted as joint book-running managers for the offering. Needham & Company, Wedbush PacGrow Life Sciences and FBR acted as co-managers.
read full: http://finance.yahoo.com/news/regulus-announces-closing-public-offering-210500751.html
*********************************************************
Mon, 03 Nov 2014 13:24:00 GMT ~ Super Important Biotech and Drug Stock Events for November
read full: http://www.thestreet.com/story/12937049/1/super-important-biotech-and-drug-stock-events-for-november.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Thu, 30 Oct 2014 21:13:02 GMT ~ Regulus Announces Timing for Third Quarter 2014 Financial Results Webcast and Conference Call
[at noodls] - LA JOLLA, Calif., Oct. 30, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, ...
read full: http://www.noodls.com/view/2788C0E533DA36291ADC25DD15A5A2F58F81C201
*********************************************************
$RGLS charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$RGLS company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/RGLS/company-info
Ticker: $RGLS
OTC Market Place: Not Available
CIK code: not found
Company name: Regulus Therapeutics Inc.
Incorporated In:
Business Description:
$RGLS share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$RGLS extra dd links
Company name: Regulus Therapeutics Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=RGLS+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=RGLS+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=RGLS+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/RGLS/news - http://finance.yahoo.com/q/h?s=RGLS+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/RGLS/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/RGLS/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=RGLS+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/RGLS
DTCC (dtcc.com): http://search2.dtcc.com/?q=Regulus+Therapeutics+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Regulus+Therapeutics+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Regulus+Therapeutics+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/RGLS
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/RGLS/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/RGLS/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=RGLS&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=RGLS
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/RGLS/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=RGLS+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=RGLS+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=RGLS
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=RGLS
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=RGLS+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/RGLS/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=RGLS+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/RGLS.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=RGLS
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/RGLS/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/RGLS/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/RGLS
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/RGLS
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/RGLS:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=RGLS
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=RGLS
$RGLS DD Notes ~ http://www.ddnotesmaker.com/RGLS
Recent RGLS News
- Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences • PR Newswire (US) • 08/28/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:24:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:16:03 PM
- Regulus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Updates • PR Newswire (US) • 08/08/2024 08:05:00 PM
- Regulus Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference • PR Newswire (US) • 08/06/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/29/2024 08:18:02 PM
- Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences • PR Newswire (US) • 07/09/2024 12:00:00 PM
- This Biotech Wasted No Time Stealing The Premarket Show • AllPennyStocks.com • 06/24/2024 02:00:00 PM
- Regulus Therapeutics Announces Positive Topline Data from the Third Cohort of Patients in its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) • PR Newswire (US) • 06/24/2024 11:00:00 AM
- Regulus Therapeutics Announces Expected Addition to the Russell 3000® and Russell 2000® Indexes • PR Newswire (US) • 06/04/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 08:23:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 08:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 08:22:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 08:22:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 08:21:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 08:20:55 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/20/2024 08:11:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:16:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:44:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:38:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:33:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:01 PM
- Regulus Therapeutics Announces Promotion of Rekha Garg, M.D., M.S., to Chief Medical Officer • PR Newswire (US) • 05/16/2024 12:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/09/2024 08:54:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:27:12 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM